Evidence map›Paper›PMID 30707224›Full record

ArticleJAMA network open2019

Prevention of Prescription Opioid Misuse and Projected Overdose Deaths in the United States.

Qiushi Chen, Marc R Larochelle, Davis T Weaver, Anna P Lietz, Peter P Mueller, Sarah Mercaldo, Sarah E Wakeman, Kenneth A Freedberg, Tiana J Raphel, Amy B Knudsen and 2 more

Registry-linked trialAbstract read
In one paragraph

Article in JAMA network open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04589676 (Developing and Testing the Opioid Rapid Response System), which is not on this map. Cited by 124 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
124citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04589676 nacompletednot on this mapstarted 2020, after this paper: background citation

Developing and Testing the Opioid Rapid Response System

TypeinterventionalSponsorReal Prevention, LLCRan2020 to 2021Enrolled400ConditionsOpioid OverdoseArmsNaloxone training
3 · Its place in the literature

Who cites it

124 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022.MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports · 2022
    Guideline
  3. Pooled it
  4. Economic Evaluation in Opioid Modeling: Systematic Review.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2021
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Hypnotic Enhancement of Virtual Reality Distraction Analgesia during Thermal Pain:The International journal of clinical and experimental hypnosis
    Trial
  14. Article
  15. Article
  16. A systematic approach to develop and characterize a compositionally equivalent buprenorphine in situ forming implant (Sublocade®).Journal of controlled release : official journal of the Controlled Release Society · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Article

64 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Qiushi ChenHarold and Inge Marcus Department of Industrial and Manufacturing Engineering, Pennsylvania State University, University Park, Pennsylvania.
Marc R LarochelleClinical Addiction Research and Education Unit, Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts.
Davis T WeaverInstitute for Technology Assessment, Department of Radiology, Massachusetts General Hospital, Boston.
Anna P LietzInstitute for Technology Assessment, Department of Radiology, Massachusetts General Hospital, Boston.
Peter P MuellerInstitute for Technology Assessment, Department of Radiology, Massachusetts General Hospital, Boston.
Sarah MercaldoInstitute for Technology Assessment, Department of Radiology, Massachusetts General Hospital, Boston.
Sarah E WakemanHarvard Medical School, Boston, Massachusetts.
Kenneth A FreedbergHarvard Medical School, Boston, Massachusetts.
Tiana J RaphelUniversity of Texas Southwestern Medical School, Dallas.
Amy B KnudsenInstitute for Technology Assessment, Department of Radiology, Massachusetts General Hospital, Boston.
Pari V PandharipandeInstitute for Technology Assessment, Department of Radiology, Massachusetts General Hospital, Boston.
Jagpreet ChhatwalInstitute for Technology Assessment, Department of Radiology, Massachusetts General Hospital, Boston.

Funding

Improving urine drug test utility to mitigate prescription opioid riskK23DA042168 · NIDA · BOSTON MEDICAL CENTER · PI LAROCHELLE, MARC · 2017 to 2021
$956k
NIDA NIH HHS K23 DA042168
6 · The paper itself

Abstract

Importance: Deaths due to opioid overdose have tripled in the last decade. Efforts to curb this trend have focused on restricting the prescription opioid supply; however, the near-term effects of such efforts are unknown. Objective: To project effects of interventions to lower prescription opioid misuse on opioid overdose deaths from 2016 to 2025. Design, Setting, and Participants: This system dynamics (mathematical) model of the US opioid epidemic projected outcomes of simulated individuals who engage in nonmedical prescription or illicit opioid use from 2016 to 2025. The analysis was performed in 2018 by retrospectively calibrating the model from 2002 to 2015 data from the National Survey on Drug Use and Health and the Centers for Disease Control and Prevention. Interventions: Comparison of interventions that would lower the incidence of prescription opioid misuse from 2016 to 2025 based on historical trends (a 7.5% reduction per year) and 50% faster than historical trends (an 11.3% reduction per year), vs a circumstance in which the incidence of misuse remained constant after 2015. Main Outcomes and Measures: Opioid overdose deaths from prescription and illicit opioids from 2016 to 2025 under each intervention. Results: Under the status quo, the annual number of opioid overdose deaths is projected to increase from 33 100 in 2015 to 81 700 (95% uncertainty interval [UI], 63 600-101 700) in 2025 (a 147% increase from 2015). From 2016 to 2025, 700 400 (95% UI, 590 200-817 100) individuals in the United States are projected to die from opioid overdose, with 80% of the deaths attributable to illicit opioids. The number of individuals using illicit opioids is projected to increase by 61%-from 0.93 million (95% UI, 0.83-1.03 million) in 2015 to 1.50 million (95% UI, 0.98-2.22 million) by 2025. Across all interventions tested, further lowering the incidence of prescription opioid misuse from 2015 levels is projected to decrease overdose deaths by only 3.0% to 5.3%. Conclusions and Relevance: This study's findings suggest that interventions targeting prescription opioid misuse such as prescription monitoring programs may have a modest effect, at best, on the number of opioid overdose deaths in the near future. Additional policy interventions are urgently needed to change the course of the epidemic.

Indexed as

Drug OverdosePrescription Drug MisuseAnalgesics, OpioidHumansModels, StatisticalRetrospective StudiesUnited StatesAnalgesics, Opioid

Identifiers

PMID30707224
PMCPMC6415966

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.